{
    "Trade/Device Name(s)": [
        "IMPACT Dx Factor V Leiden and Factor II Genotyping Test",
        "IMPACT Dx System",
        "IMPACT Dx NANO",
        "IMPACT Dx MA",
        "TYPER Dx Software"
    ],
    "Submitter Information": "Sequenom, Inc.",
    "510(k) Number": "K132978",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033607",
        "K033612",
        "K033734",
        "K060564"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PHJ"
    ],
    "Summary Letter Date": "June 13, 2014",
    "Summary Letter Received Date": "May 14, 2014",
    "Submission Date": "May 13, 2014",
    "Regulation Number(s)": [
        "21 CFR 864.7280"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA Mutation Detection Systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor V gene (G1691A mutation)",
        "Factor II gene (G20210A mutation)",
        "Prothrombin gene"
    ],
    "Specimen Type(s)": [
        "Genomic DNA isolated from EDTA anti-coagulated human whole blood samples"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IMPACT Dx System",
        "IMPACT Dx NANO",
        "IMPACT Dx MA"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Single base primer extension",
        "Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)"
    ],
    "Methodologies": [
        "Genotyping",
        "Allele-specific single nucleotide extension",
        "Mass spectrometry analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "System",
        "Software",
        "Reagent",
        "Panel",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Sequenom IMPACT Dx Factor V Leiden and Factor II Genotyping Test using MALDI-TOF mass spectrometry for detection of hereditary thrombophilia mutations.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic genotyping test for detection and genotyping of Factor V Leiden (G1691A) and Factor II (G20210A) mutations from EDTA anti-coagulated human whole blood as an aid in diagnosis of patients with suspected thrombophilia.",
    "fda_folder": "Hematology"
}